Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
25 hedge funds and large institutions have $1.45M invested in Alexza Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
4% less funds holding
Funds holding: 26 → 25 (-1)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
59% less capital invested
Capital invested by funds: $3.5M → $1.45M (-$2.05M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$13.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$9.29K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.36K |
| 4 |
Bank of New York Mellon
New York
|
+$763 |
| 5 |
First Manhattan
New York
|
+$438 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$81.4K |
| 2 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$26.7K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$20K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.49K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.78K |
ALXA Hedge Fund Activity: Q1 2016 in Review
25 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q1 2016, worth a combined $1.45M — down 59% from $3.5M a quarter earlier.
Fund positioning in ALXA was balanced in Q1 2016: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 6 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $13.2K. The largest seller was Morgan Stanley, cutting an estimated $81.4K.
- 25 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q1 2016, down from 26 in Q4 2015.
- Funds reported $1.45M of Alexza Pharmaceuticals Inc stock for Q1 2016, down 59% quarter-over-quarter.
- 3 funds opened new Alexza Pharmaceuticals Inc positions in Q1 2016 and 3 closed out, a net change of 0 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q1 2016 was Goldman Sachs, an estimated $13.2K added.
- The largest Alexza Pharmaceuticals Inc seller in Q1 2016 was Morgan Stanley, an estimated $81.4K sold.
Based on aggregated 13F filings for Q1 2016.